ALNY - ALNYLAM PHARMACEUTICALS, INC.
320.66
0.150 0.047%
Share volume: 983,222
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$320.51
0.15
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 10-31-2024 | 02-13-2025 | 05-01-2025 | 07-31-2025 | 10-30-2025 | 02-12-2026 | |
| Assets | |||||||||
| Total Assets | 3.824 B | 4.010 B | 4.205 B | 4.240 B | 4.214 B | 4.566 B | 4.852 B | 4.966 B | |
| Current Assets | 2.989 B | 3.173 B | 3.355 B | 3.295 B | 3.268 B | 3.644 B | 3.953 B | 4.051 B | |
| Inventories | 93.988 M | 83.981 M | 75.987 M | 78.509 M | 65.581 M | 71.688 M | 75.383 M | 82.719 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 1.689 B | 1.656 B | 1.680 B | 1.728 B | 1.613 B | 1.744 B | 1.234 B | 1.251 B | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 681.879 M | 968.492 M | 1.100 B | 966.428 M | 1.020 B | 1.114 B | 1.490 B | 1.657 B | |
| Total Non-current Assets | 49.390 M | 49.391 M | 68.592 M | 68.593 M | 68.592 M | 68.593 M | 51.314 M | 22.170 M | |
| Property Plant Equipment | 523.460 M | 517.159 M | 506.997 M | 502.784 M | 498.684 M | 499.791 M | 501.754 M | 513.147 M | |
| Other Assets | 312.319 M | 319.619 M | 342.618 M | 441.914 M | 446.869 M | 422.529 M | 397.097 M | 402.522 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 3.824 B | 4.010 B | 4.205 B | 4.240 B | 4.214 B | 4.566 B | 4.852 B | 4.966 B | |
| Total liabilities | 4.044 B | 4.013 B | 4.173 B | 4.173 B | 4.098 B | 4.315 B | 4.618 B | 4.177 B | |
| Total current liabilities | 941.709 M | 1.055 B | 1.221 B | 1.186 B | 1.076 B | 1.301 B | 1.555 B | 1.466 B | |
| Accounts Payable | 78.148 M | 73.980 M | 70.805 M | 88.415 M | 97.399 M | 102.393 M | 117.591 M | 115.721 M | |
| Other liabilities | 1.895 B | 1.932 B | 1.927 B | 1.962 B | 1.997 B | 1.988 B | 2.022 B | 1.703 B | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 1.022 B | 1.023 B | 1.024 B | 1.025 B | 1.026 B | 1.027 B | 1.040 B | 1.008 B | |
| Other liabilities | 1.895 B | 1.932 B | 1.927 B | 1.962 B | 1.997 B | 1.988 B | 2.022 B | 1.703 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -219.272 M | -3.067 M | 32.354 M | 67.088 M | 115.435 M | 250.591 M | 233.894 M | 789.176 M | |
| Common stock | 6.883 B | 7.124 B | 7.261 B | 7.389 B | 7.498 B | 7.692 B | 7.416 B | 7.512 B | |
| Retained earnings | -7.076 B | -7.092 B | -7.204 B | -7.288 B | -7.345 B | -7.412 B | -7.160 B | -6.703 B |